Does UPADACITINIB Cause Joint swelling? 1,090 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,090 reports of Joint swelling have been filed in association with UPADACITINIB (Rinvoq). This represents 1.7% of all adverse event reports for UPADACITINIB.
1,090
Reports of Joint swelling with UPADACITINIB
1.7%
of all UPADACITINIB reports
80
Deaths
309
Hospitalizations
How Dangerous Is Joint swelling From UPADACITINIB?
Of the 1,090 reports, 80 (7.3%) resulted in death, 309 (28.3%) required hospitalization, and 87 (8.0%) were considered life-threatening.
Is Joint swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 1,090 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Joint swelling?
ETANERCEPT (18,462)
ABATACEPT (18,453)
ADALIMUMAB (18,266)
METHOTREXATE (17,657)
TOCILIZUMAB (14,831)
LEFLUNOMIDE (13,026)
HYDROXYCHLOROQUINE (11,353)
RITUXIMAB (11,170)
TOFACITINIB (10,686)
INFLIXIMAB (9,853)
Which UPADACITINIB Alternatives Have Lower Joint swelling Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL